Skip to main navigation Skip to search Skip to main content

Clarametyx 2021-07: Pharmacokinetics of submitted test article in naive and P. aeruginosa lung infected mice

Project Details

StatusFinished
Effective start/end date28/09/21 → 9/07/22

Funding

  • Clarametyx Biosciences, Inc.: $27,497.30

Keywords

  • Biotechnology & Drug Development, Infectious Diseases